(1)
Di Bartolomeo, E.; Santarone, S.; Bavaro, P.; Di Carlo, P.; Olioso, P.; Papalinetti, G.; Di Bartolomeo, P. Once-Daily Intravenous Busulfan As Myeloablative, Reduced-Toxicity Conditioning Regimen: Results in Young and Adult Patients With Hematological Malignant and Nonmalignant Diseases. Hematol Meeting Rep 2009, 2.